How do patients feel during the first 72 h after initiating long-acting injectable buprenorphine? An embodied qualitative analysis
Saved in:
Neale, J., et al., How do patients feel during the first 72 h after initiating long-acting injectable buprenorphine? An embodied qualitative analysis. Addiction, vol. 118, n. 7, 2023, p. 1329-1339.
Ref.
586599
Location:
SIIS Archivo (R.696)
Palabras clave:
Drogodependencias, Drogas ilegales, Opiáceos, Tratamiento, Innovaciones, Buprenorfina, Vía intravenosa, Actitudes usuarios, Beneficios, Efectos no deseados, Emociones, Bienestar, Salud, Estudio cualitativo, Reino Unido
Drogodependencias, Drogas ilegales, Opiáceos, Tratamiento, Innovaciones, Buprenorfina, Vía intravenosa, Actitudes usuarios, Beneficios, Efectos no deseados, Emociones, Bienestar, Salud, Estudio cualitativo, Reino Unido
Similar Items: How do patients feel during the first 72 h after initiating long-acting injectable buprenorphine? An embodied qualitative analysis
- Conceptualising retention in treatment with long-acting injectable buprenorphine (for opioid use disorder) as a journey: Findings from a longitudinal qualitative study
- ‘Matters-of-concern’ associated with discontinuation of long-acting injectable buprenorphine: Findings from a longitudinal qualitative study
- Squalor, chaos and feelings of disgust: care workers talk about older people with alcohol problems
- The practice and embodiment of “goofballs ”: A qualitative study exploring the co-injection of methamphetamines and opioids
- “To smoke feels gender”: Exploring the transformative and emancipatory capacities of cannabis among transgender, non-binary and gender non-conforming (TGNC) youth
- Efectos psicológicos del confinamiento por pandemia de Covid-19 en una muestra en tratamiento de adicciones en España